Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-011112
Filing Date
2020-01-21
Accepted
2020-01-21 17:03:05
Documents
1
Group Members
ERIC ROBERTSEVGENY ZAYTSEVGRAHAM CROOKEPHILIP SAWYERRACHEL LEHENYVALENCE HELIX INVESTMENTS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d869958dsc13da.htm SC 13D/A 143856
  Complete submission text file 0001193125-20-011112.txt   145650
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Subject) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90188 | Film No.: 20536912
SIC: 2834 Pharmaceutical Preparations

Mailing Address 590 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10022 212-521-4379
Valence Helix Investments III, LLC (Filed by) CIK: 0001767901 (see all company filings)

EIN.: 833347149 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A